BBH ETF
VanEck Biotech ETF
BBH ETF Overview
BBH ETF (VanEck Biotech ETF) is managed by VanEck with $406.1M in net assets. BBH expense ratio is 0.35%, holding 26 positions across sectors including Health Care, Information Technology. Inception date: 2011-12-20.
BBH performance shows a YTD return of 8.58%. The 1-year return is 27.31% and the 5-year return is 0.65%. BBH dividend yield stands at 0.46%, paid annually.
BBH top holdings include Amgen Inc. (16.6%), Gilead Sciences (12.9%), Nvaesrtex Pharmaceuticals Inc (8.6%), Regeneron Pharmaceuticals, Inc. (7.4%), Revolution Medicines Inc (5.4%). Go to all BBH holdings, BBH sectors, or BBH dividends.
BBH can be compared against other funds. Use BBH overlap to find shared positions, or BBH vs another fund for a side-by-side view. BBH alternatives are available via the screener, along with tax-loss harvesting opportunities.